Quest Diagnostics documents subpoenaed
This article was originally published in The Gray Sheet
Quest and its test kit manufacturing subsidiary, Nichols Institute Diagnostics, will supply the U.S. Department of Justice with requested documents related to vitamin D therapies and FDA-cleared tests for measuring parathyroid hormone (PTH) levels. Similar subpoenas were received the week of Oct. 25 by several other dialysis-related product and service providers, including Fresenius Medical. Chronic kidney disease patients often produce dangerous levels of PTH when calcium reabsorption, phosphate excretion and vitamin D production levels are low. Vitamin D analogs, such as Abbott's Zemplar, help regulate PTH. Both Quest and Fresenius maintain that sales of PTH tests and related equipment account for 1% or less of overall revenue...
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.